https://www.contagionlive.com/view/antibiotic-development-glass-half-full-or-half-empty-
A clinician offers his perspective on what he sees as a clinician and trial investigator in terms of what is in the pipeline and both the encouraging data and uncertainty in therapy development overall.
Create an account or login to join the discussion